Source link : https://www.newshealth.biz/health-news/fda-adds-new-warning-to-glp-1-drugs/
Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep sedation. The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), and lixisenatide (Adlyxin). This drug class, involving injectable and oral […]
Author : News Health
Publish date : 2024-11-08 21:56:00
Copyright for syndicated content belongs to the linked Source.